| Kaitlyn Shrake, MD | |
|
1000 S Limestone, Lexington, KY 40536-0001 | |
| (859) 323-9057 | |
| (859) 323-9502 |
| Full Name | Kaitlyn Shrake |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 1000 S Limestone, Lexington, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316470412 | NPI | - | NPPES |
| Entity Name | University Of Kentucky |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770771974 PECOS PAC ID: 3072425289 Enrollment ID: O20031105000072 |
News Archive
The precision medicine approach involving DNA sequencing to pinpoint specific alterations that can be targeted with anti-cancer therapies is becoming an alternate treatment avenue for those with poor-responding cancers.
Atherosclerosis is a disease in which arteries narrow due to plaques. That narrowing can lead to heart attacks and strokes - both of which are leading causes of death in the U.S.
Joslin Diabetes Center will take part in two clinical trials this year to test artificial pancreas systems designed to automatically monitor and regulate blood glucose levels in people with type 1 diabetes, which would replace traditional methods of managing the disease such as testing blood glucose levels by finger stick or using continuous glucose monitoring systems with separate, non-integrated delivery of insulin by either injections or a pump.
To assist the millions of Americans living with psoriasis, the most common autoimmune disease in the country, the National Psoriasis Foundation published the most recent guidelines in the United States for the management of plaque psoriasis—the most prevalent form of the disease, affecting roughly 80 percent of people with psoriasis.
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today the presentation of data for EBI-005, the first IL-1 (Interleukin-1) signaling inhibitor designed for topical ocular administration, at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting in Seattle, Washington.
› Verified 5 days ago
| Entity Name | Kentucky Medical Services Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326091448 PECOS PAC ID: 5698689909 Enrollment ID: O20031119000300 |
News Archive
The precision medicine approach involving DNA sequencing to pinpoint specific alterations that can be targeted with anti-cancer therapies is becoming an alternate treatment avenue for those with poor-responding cancers.
Atherosclerosis is a disease in which arteries narrow due to plaques. That narrowing can lead to heart attacks and strokes - both of which are leading causes of death in the U.S.
Joslin Diabetes Center will take part in two clinical trials this year to test artificial pancreas systems designed to automatically monitor and regulate blood glucose levels in people with type 1 diabetes, which would replace traditional methods of managing the disease such as testing blood glucose levels by finger stick or using continuous glucose monitoring systems with separate, non-integrated delivery of insulin by either injections or a pump.
To assist the millions of Americans living with psoriasis, the most common autoimmune disease in the country, the National Psoriasis Foundation published the most recent guidelines in the United States for the management of plaque psoriasis—the most prevalent form of the disease, affecting roughly 80 percent of people with psoriasis.
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today the presentation of data for EBI-005, the first IL-1 (Interleukin-1) signaling inhibitor designed for topical ocular administration, at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting in Seattle, Washington.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaitlyn Shrake, MD 473 W 12th Ave # Dhlri201, Columbus, OH 43210-1252 Ph: (614) 247-7701 | Kaitlyn Shrake, MD 1000 S Limestone, Lexington, KY 40536-0001 Ph: (859) 323-9057 |
News Archive
The precision medicine approach involving DNA sequencing to pinpoint specific alterations that can be targeted with anti-cancer therapies is becoming an alternate treatment avenue for those with poor-responding cancers.
Atherosclerosis is a disease in which arteries narrow due to plaques. That narrowing can lead to heart attacks and strokes - both of which are leading causes of death in the U.S.
Joslin Diabetes Center will take part in two clinical trials this year to test artificial pancreas systems designed to automatically monitor and regulate blood glucose levels in people with type 1 diabetes, which would replace traditional methods of managing the disease such as testing blood glucose levels by finger stick or using continuous glucose monitoring systems with separate, non-integrated delivery of insulin by either injections or a pump.
To assist the millions of Americans living with psoriasis, the most common autoimmune disease in the country, the National Psoriasis Foundation published the most recent guidelines in the United States for the management of plaque psoriasis—the most prevalent form of the disease, affecting roughly 80 percent of people with psoriasis.
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today the presentation of data for EBI-005, the first IL-1 (Interleukin-1) signaling inhibitor designed for topical ocular administration, at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting in Seattle, Washington.
› Verified 5 days ago
Mr. Fabrizio Canepa Escaro, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Uk Division Of Hospital Medicine 800 Rose, Lexington, KY 40536 Phone: 859-323-6047 Fax: 859-257-3873 | |
Dr. Moneera Nur Haque, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 125 E Maxwell St Ste 200, Lexington, KY 40508 Phone: 859-323-3231 Fax: 859-257-9461 | |
Dr. Indhira Bisono Jimenez, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 211 Fountain Ct, Suite 220, Lexington, KY 40509 Phone: 859-629-7265 Fax: 859-629-7266 | |
Deepali Pandey, MBBS Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 800 Rose St # Cc-402, Lexington, KY 40536 Phone: 650-804-3111 | |
Dr. Dorothy Mccord Maes, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1000 S Limestone, Lexington, KY 40536 Phone: 859-323-9057 Fax: 859-323-9502 | |
Dr. Stephen M Mooney, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2101 Nicholasville Rd Ste 304, Lexington, KY 40503 Phone: 859-277-5771 Fax: 859-276-4622 | |
Michael Han Young, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 740 S Limestone, Lexington, KY 40536 Phone: 859-323-5544 Fax: 859-257-9286 |